Gilead develops solid tumour cell therapy with Gadeta
Gilead has option to buy biotech if things go well
X
Gilead develops solid tumour cell therapy with Gadeta
https://pharmaphorum.com/news/gilead-develops-solid-tumour-cell-therapy-with-gadeta/
Gilead
Gilead takes ‘HIV eradication’ combo into clinic
New approach tackles reserve of HIV within the body
US judge overturns Gilead $2.54bn patent infringement ruling
Federal judge throws out Merck’s patent claim against Gilead
Cellectis confident on ‘off the shelf’ CAR-Ts despite setbacks
US hospitals struggle to provide approved autologous therapies
Kymriah gets fast DLBCL review in US and Europe
Fast reviews set up showdown with Gilead
Gilead goes full throttle on CAR-Ts with $567m acquisition
Gilead hopes CDL technology will create therapies targeting solid tumours
Gilead gains CAR-T approval, undercuts rival’s headline price
Cancer cell therapy approved for aggressive blood cancer
